Skip to content

PET - PEEP by EIT for Acute Respiratory Distress Syndrome Trial

EIT-guided PEEP Titration Versus Low PEEP/FiO2 Table for ARDS: a Multicenter, Randomized, Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05307913
Enrollment
676
Registered
2022-04-01
Start date
2022-04-10
Completion date
2025-05-10
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Human

Keywords

electrical impedance tomography, ARDS, PEEP

Brief summary

This study is a multicentric randomized controlled study.The objective of this study is to compare the prognosis of patients with ARDS between EIT-oriented individualized PEEP and traditional lower PEEP/FiO2 table-oriented PEEP strategy.

Interventions

PEEP setting according to EIT

OTHERTable-guided PEEP

PEEP setting according to the lower PEEP/FiO2 table

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Intubated, mechanically ventilated patients with diagnosis of ARDS according to ARDS Berlin standard by attending doctor

Exclusion criteria

1. Age \< 18 years old and \> 90 years old; 2. Pregnancy; 3. EIT contradictions (presence of pacemaker or automatic implantable cardioverter defibrillator); 4. Severe intracranial hypertension; 5. Pneumothorax, pneumomediastinum, subcutaneous emphysema or at high-risk for pneumothorax (e.g., pneumatocele, interstitial lung disease); 6. Unstable hemodynamic status intorerable to lung recruitment and PEEP titration, judged by an attending intensivist; (This may be a transient criterion, since patients meeting this criterion might be included later if hemodynamics improves) 7. End status of disease; 8. Patients or their families refused to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Survival in 28 days28 daysSurvival within 28 days from randomization

Secondary

MeasureTime frameDescription
Lenght of ICU stayMaximum 6-monthsLength of hospital stay from randomization to ICU discharge
Lenght of hospital stayMaximum 6-monthsLength of hospital stay from randomization to hospital discharge
28-day ventilator-free days28 daysNumber of days alive and out of mechanical ventilation between randomization and 28 days after randomization.
Barotrauma7 daysWe consider as barotrauma within 7 days any pneumothorax, pneumomediastinum, subcutaneous emphysema or pneumatocele \> 2cm detected on image exams between randomization and 7 days, except those judged to be clearly caused by invasive procedures.
ICU survivalMaximum 6-monthsSurvival at ICU discharge.
hospital survivalMaximum 6-monthsSurvival at hospital discharge.
change of Sequential Organ Failure Assessment (SOFA) score2 dayschange of SOFA score within first 2 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026